2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has…
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
Should You Add a Healthcare Stock to Your Portfolio This Month? And Should It Be Eli Lilly (LLY)?
If you’re looking to add to your long-term stock portfolio, it can make good sense to consider a…
The Healthcare Stocks I’d Buy Without Hesitation
With the Nasdaq Composite recently hitting correction territory, many investors fear that we will enter a full-blown bear…
2 Healthcare Stocks for Long-Term Investors and 1 We Ignore
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite…
2 AI Healthcare Stocks to Buy Right Now
While the advent of artificial intelligence (AI) has obviously changed the world, not every utilization of AI has…
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players…
2 Top AI Healthcare Stocks to Buy and Hold
Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…
What’s the Better Long-Term Investment?
Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are rivals in the GLP-1 drug market and are…
Trump’s Flat Rate Medicare Advantage Proposal Is ‘Shock To The System,’ Risking 20% Earnings Hit, Delaying Healthcare Turnaround
Healthcare stocks have been in focus after the Donald Trump administration proposed a near-zero increase in Medicare Advantage…
1 Healthcare Stock to Target This Week and 2 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders…
1 Healthcare Giant Set to Soar in 2026
Novo Nordisk cut its guidance and changed its CEO this past year. Amid the troubling developments, the stock…